Clinical Actionability of Genetic Findings in Cerebral Palsy
Sara A. Lewis(Barrow Neurological Institute), Michael C. Kruer(Barrow Neurological Institute), Maya Chopra(Boston Children's Hospital), Jason B. Carmel(United Cerebral Palsy), Darcy Fehlings(University of Toronto), Jennifer Bain(Columbia University Irving Medical Center), Halie May(Columbia University Irving Medical Center), Julie S. Cohen(Kennedy Krieger Institute), Richard F. Wintle(Hospital for Sick Children), Reeval Segel(Shaare Zedek Medical Center), Michael Zech(Helmholtz Zentrum München), Siddharth Srivastava(Boston Children's Hospital), Bhooma R. Aravamuthan(Washington University in St. Louis), N Haque(Barrow Neurological Institute), Michael Fahey(Monash University)
Cited by 12
Related Papers
Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies
|The Lancet Neurology|2014|615
Danube loess stratigraphy — Towards a pan-European loess stratigraphic model
|Earth-Science Reviews|2015|313
Acute Infantile Liver Failure Due to Mutations in the TRMU Gene
|The American Journal of Human Genetics|2009|227
A large data resource of genomic copy number variation across neurodevelopmental disorders
|npj Genomic Medicine|2019|199